指南与共识技术与安全

ACR适宜性标准®:黑色素瘤的分期与随访

ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma.
指南 / 共识 · J Am Coll Radiol · 2026-03-12

本文概述了皮肤、黏膜皮肤及眼部黑色素瘤分期与监测中不同影像检查方式的证据,并按淋巴结状态、基线转移、疑似转移及局部分期给出推荐。美国放射学院适宜性标准为循证指南,每年由多学科专家组复核,采用GRADE等方法评价证据。

要点

  • 指南按淋巴结状态、基线转移、疑似转移及局部分期分层推荐影像检查。
  • 证据来自同行评议文献,采用GRADE等方法评价,缺乏证据时以专家意见为推荐依据。
  • 指南由多学科专家组每年复核更新。

核心结论

  • 本文提供支持皮肤、黏膜皮肤及眼部黑色素瘤分期与监测所用不同影像检查方式与技术的证据概述。

研究设计与样本

  • 美国放射学院适宜性标准为循证指南,针对特定临床情况,由多学科专家组每年复核。
  • 指南制定与修订过程系统分析同行评议期刊的医学文献,采用GRADE等既定方法学原则评价证据。
  • 采用RAND/UCLA适宜性方法用户手册确定特定临床场景中影像与治疗程序的适宜性。
  • 同行评议文献缺乏或不确定时,专家可能是形成推荐的主要证据来源。

诊断标准与关键数值

  • 按淋巴结状态、基线时转移存在情况、疑似转移及局部分期提供推荐。

临床应用与阅片要点

  • 原文未据此给出具体阅片或报告操作建议。

局限性

  • 同行评议文献缺乏或不确定时,专家可能是形成推荐的主要证据来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This document provides a comprehensive overview of the evidence supporting different imaging modalities and techniques used for the staging and surveillance of patients with cutaneous, mucocutaneous, and ocular melanoma. Guidelines are provided based on nodal status, presence of metastases at baseline, suspected metastases, and local stage. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Mejias C, Morgan RL, Arora SS, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma. J Am Coll Radiol. 2026. PMID: 41823939. doi:10.1016/j.jacr.2026.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。